Stress urinary incontinence after holmium laser enucleation of prostate: incidence and risk factors

Background and objective: To evaluate the incidence and the risk factors of stress urinary incontinence (SUI) during the first year following Holmium Laser Enucleation of the Prostate (HoLEP). Materials and methods: Our monocentric and retrospective study includes 155 patients who underwent HoLEP for benign prostatic hyperplasia. Surgeries were performed by 2 expert surgeons. The continence was evaluated before and after surgery at 1, 3, 6 and 12 months. The predictive factors of SUI were analysed using logistic regression. Results: The SUI rate at 1, 3, 6 and 12 months was respectively 7.3%, 8.1%, 3.4% and 2.7%. SUI remained present in 4 patients (2.6%) at 12 months. The mean International Consultation Incontinence Questionnaire Urinary Incontinence Short Form (ICIQ-SF) score for patients with SUI was respectively 11.69 ± 5.28, 8.70 ± 4.24, 1.81 ± 3.53 and 8 ± 4.24 at 1, 3, 6 and 12 months (p 30 (Odds Ratio (OR), 4.69; 95% Confidence Interval (CI), 1.51–14.52; p = 0.007) and patients over 70 years old (OR, 16.23; 95% CI, 1.96–134.09; p = 0.010) were respectively identified as independent risk factors for SUI at 1 and 3 months. Conclusions: SUI after HoLEP is transitory in most cases. It is favoured by a high BMI and an age over 70. These criteria should be considered before choosing the operative technique and preventive measures must be taken in high-risk patients

Ischemia-reperfusion : impact of renal perfusion on grafts function

La pénurie d'organes a amené les équipes de transplantation à élargir l'acceptation des greffons à des organes provenant de donneurs marginaux.Le recours aux greffons marginaux impose de réduire les lésions induites durant l'IR, et doit conduire à une prise en charge optimisée de façon à limiter le risque de PNF et de RRF.C'est face à cette situation, que la question de la perfusion d'organe et de l'utilisation des machines de perfusion s'est posée et a justifié la réalisation de ce travail.Un modèle d'autotransplantation chez le porc a été choisi car il permet d'évaluer les effets de l'IR sur le rein.Les reins ont subi une ischémie contrôlée. La conservation des reins a été randomisée soit en incubation statique dans IGL-1 ou Belzer MPS soit sur machine de perfusion.Nous avons utilisé comme paramètre d'étude : la survie des animaux, différents dosages biologiques, une analyse histologique et une évaluation immunologique par RTqPCR des certains gènes impliqués dans le mécanisme lésionnel d'IR.Nos résultats montrent au total :-Que la machine de perfusion RM3 diminue le risque de RRF et PNF post greffe.-La supériorité de l'IGL-1 sur le Belzer MPS ; il existe un effet propre de la solution IGL-1 pour moduler les mécanismes inflammatoires et immunologiques liés aux lésions d'IR.-Que la reprise de fonction et la PNF dépendent du liquide utilisé et qu'il existe un effet d'addition entre l'IGL-1 et la machine de perfusion.Organ shortage has led transplant teams to re-evaluate their acceptance criteria and to increase their use of marginal donor organs (ECD and DDAC). For this reason, it is necessary to reduce the lesions due to IR. By optimizing organ conservation, the risk of PNF and RRF can be limited, and organ survival increased. The question of organ perfusion and the use of perfusion machines arose in this context, leading to the work we present here.We chose to evaluate the effects of IR on a porcine auto-graft model, that being the gold standard for the study of IR lesions.The kidneys were subject to hot ischemia for 60 minutes, and then to cold ischemia for 22 hours, during which they were randomly conserved either through static incubation in IGL-1 or Belzer MPS or on a perfusion machine.We studied the animal survival rate, various bioassays, histological analysis and immune reactions though RTqPCR of certain genes involved in IR lesion mechanisms.Our results show:-That the RM3 perfusion machine decreases the RRF and PNF post-graft risk and thus the perfusion machine conservation is better than static conservation.-IGL-1 superiority over Belzer MPS; IGL-1 solution independently modulates inflammatory and immunological mechanisms linked to IR lesions.-That function recovery and PNF depend on the liquid used where there is an additive effect between the use of IGL-1 and the use of a perfusion machine

Chronic renoprotective effect of pulsatile perfusion machine RM3 and IGL-1 solution in a preclinical kidney transplantation model

<p>Abstract</p> <p>Background</p> <p>Machine perfusion (MP) of kidney graft provides benefits against preservation injury, however decreased graft quality requires optimization of the method. We examined the chronic benefits of MP on kidney grafts and the potential improvements provided by IGL-1 solution.</p> <p>Method</p> <p>We used an established autotransplantation pig kidney model to study the effects of MP against the deleterious effects of warm ischemia (WI: 60 minutes) followed by 22 hours of cold ischemia in MP or static cold storage (CS) followed by autotransplantation. MPS and IGL-1 solutions were compared.</p> <p>Results</p> <p>Animal survival was higher in MPS-MP and both IGL groups. Creatinine measurement did not discriminate between the groups, however MPS-MP and both IGL groups showed decreased proteinuria. Chronic fibrosis level was equivalent between the groups. RTqPCR and immunohistofluorescent evaluation showed that MP and IGL-1 provided some protection against epithelial to mesenchymal transition and chronic lesions. IGL-1 was protective with both MP and CS, particularly against chronic inflammation, with only small differences between the groups.</p> <p>Conclusion</p> <p>IGL-1 used in either machine or static preservation offers similar levels of protection than standard MP. The compatibility of IGL-1 with both machine perfusion and static storage could represent an advantage for clinical teams when choosing the correct solution to use for multi-organ collection. The path towards improving machine perfusion, and organ quality, may involve the optimization of the solution and the correct use of colloids.</p

LESS living donor nephrectomy: Surgical technique and results

Purpose: We present the findings of 50 patients undergoing pure trans-umbilical laparo-endoscopic single-site surgery (LESS) living donor nephrectomy (LDN), between February 2010 and May 2014. Materials and Methods: Laparo-endoscopic single-site surgery LDN was performed through an umbilical incision. Different trocars were used, namely Gelpoint (Applied Mιdical, Rancho Santa Margarita, CA) SILS port (Covidien, Hamilton, Bermuda), R-port (Olympus Surgical, Orangeburg, NY) and standard trocars, inserted through the same skin incision but using separate fascial punctures. The standard laparoscopic technique was employed. The kidney was pre-entrapped in a retrieval bag and extracted trans-umbilically. Data were collected prospectively including questionnaires containing patient reported oral pain medication duration and time to recovery. Results: LESS LDN was successful in all patients. Mean warm ischemia time was 6.2 min (3-15), mean procedure time was 233.2 min (172-300), and hospitalization stay was 3.94 days (3-7) with a visual analogue pain score at discharge of 1.32 (0-3). No intraoperative complications occurred. The mean time of oral pain medication was 8.72 days (1-20) and final scar length was 4.06 cm (3-5). Each allograft was functional. Conclusion: Although challenging, trans-umbilical LESS LDN seems to be feasible and safe. Hence, LESS has the potential to improve cosmetic results and decrease morbidity

Role of mitochondrial modulation during kidney preservation: evaluation in a preclinical model of deceased after circulatory death donor

International audienc

Hypothermic pulsatile preservation of kidneys from uncontrolled deceased donors after cardiac arrest - a retrospective study

International audienceKidneys from uncontrolled donors after cardiac arrest (uDCD) suffer from a period of warm ischemia between cardiac arrest and cold flushing. Aim of the study was to evaluate renal outcomes of uDCD kidneys selected on the basis of renal Resistance Index (RI) and its influence on graft function and survival. The study included 44 kidneys procured from 26 uDCD starting 1.1.2006 until 12.31.2013. The donors (Maastricht category II) underwent cardiopulmonary resuscitation by assisted ventilation and chest compression; the organs were preserved with in situ cold perfusion or a normothermic regional perfusion. All kidneys were perfused on hypothermic (1-4 °C) pulsatile perfusion machine (RM3; Waters Medical System) and discarded when RI >=0.5 mmHg/ml/min after 6 h of perfusion. There was one (2.2%) primary non function, while 37 recipients (84.1%) experienced delayed graft function. Graft survival was 97.6% at 1 and 3 post-transplantation years. Linear regression models showed that lower values of RI at the end of perfusion were associated with higher values of Modification of Diet in Renal Disease at 3 (P = 0.049) and 6 months after transplantation (P = 0.010) and with higher values of inulin clearance at 1 year (P = 0.030). RI showed to be a useful tool to select uDCD kidneys allowing to achieve good clinical results

The Optimal PEG for Kidney Preservation: A Preclinical Porcine Study

University of Wisconsin (UW) solution is not optimal for preservation of marginal organs. Polyethylene glycol (PEG) could improve protection. Similarly formulated solutions containing either 15 or 20 g/L PEG 20 kDa or 5, 15 and 30 g/L PEG 35 kDa were tested in vitro on kidney endothelial cells, ex vivo on preserved kidneys, and in vivo in a pig kidney autograft model. In vitro, all PEGs provided superior preservation than UW in terms of cell survival, adenosine triphosphate (ATP) production, and activation of survival pathways. Ex vivo, tissue injury was lower with PEG 20 kDa compared to UW or PEG 35 kDa. In vivo, function recovery was identical between UW and PEG 35 kDa groups, while PEG 20 kDa displayed swifter recovery. At three months, PEG 35 kDa 15 and 30 g/L animals had worse outcomes than UW, while 5 g/L PEG 35 kDa was similar. PEG 20 kDa was superior to both UW and PEG 35 kDa in terms of function and fibrosis development, with low activation of damage pathways. PEG 20 kDa at 15 g/L was superior to 20 g/L. While in vitro models did not discriminate between PEGs, in large animal models of transplantation we showed that PEG 20 kDa offers a higher level of protection than UW and that longer chains such as PEG 35 kDa must be used at low doses, such as found in Institut George Lopez (IGL1, 1g/L)